June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Amphiregulin Antibody and Reduction of Axial Elongation in Experimental Myopia
Author Affiliations & Notes
  • Wen Jun Jiang
    Ophthalmology, Eye Institute of Shandong University of Traditonal Chinese Medicine, Jinan, Shandong, China
  • Jian Feng Wu
    Ophthalmology, Eye Institute of Shandong University of Traditonal Chinese Medicine, Jinan, Shandong, China
  • Dadong Guo
    Ophthalmology, Eye Institute of Shandong University of Traditonal Chinese Medicine, Jinan, Shandong, China
  • Hongsheng Bi
    Ophthalmology, Eye Institute of Shandong University of Traditonal Chinese Medicine, Jinan, Shandong, China
  • Jost B Jonas
    Medical Faculty Mannheim of the 16 Ruprecht-Karls-University Heidelberg,, Mannheim, Germany
  • Footnotes
    Commercial Relationships   Wen Jun Jiang, None; Jian Feng Wu, None; Dadong Guo, None; Hongsheng Bi, None; Jost Jonas, Biocompatible UK Ltd. (F)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 5470. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Wen Jun Jiang, Jian Feng Wu, Dadong Guo, Hongsheng Bi, Jost B Jonas; Amphiregulin Antibody and Reduction of Axial Elongation in Experimental Myopia. Invest. Ophthalmol. Vis. Sci. 2017;58(8):5470.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To examine the influence of an intraocularly applied antibody to amphiregulin, a bifunctional growth modulator interacting with the epithelial growth factor/tissue growth factor-α receptor, on ocular axial elongation.

Methods : Guinea pigs (age:2-3 weeks) undergoing unilateral or bilateral lens-induced myopization (group 1), and guinea pigs which were primarily myopic at baseline without additional lens-induced myopization (group 2), received unilateral intraocular injections of amphiregulin antibody (doses:5,10,or 15μg) three times in intervals of 9 days, while the contralateral eyes received intraocular injections of Ringers solution. A third group of guinea pigs with normal refractive error at baseline and without lens-induced myopization received intraocular unilateral injections of amphiregulin (doses:0.25,0.50 or 1.00ng, respectively), and injections of Ringers solution into the contralateral eyes.

Results : In intra-animal inter-eye comparison and intra-eye follow-up comparison in groups 1 and 2, the study eyes as compared to the contralateral eyes showed a dose-dependent reduction in axial elongation. In group 3, study eyes and control eyes did not differ significantly in axial elongation. Immunohistochemistry revealed amphiregulin labelling at the retinal pigment epithelium in eyes with lens-induced myopization and Ringers solution injection, but not in eyes with amphiregulin antibody injection.

Conclusions : Repeated intraocular injection of amphiregulin-antibody was associated with a reduction of lens-induced axial myopic elongation and with reduction of the physiological eye enlargement in young guinea pigs. In contrast, intraocularly injected amphiregulin in a dose of ≤1ng did not show a significant effect. Amphiregulin may be one of several essential molecular factors for axial elongation in young guinea pigs.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×